IMB Dx, Inc. (KOSDAQ:461030)
South Korea · Delayed Price · Currency is KRW 9,550.00
+20.00 (0.21%)
Jan 29, 2026, 3:30 PM KST
IMB Dx Market Cap
IMB Dx has a market cap or net worth of 133.87 billion as of January 29, 2026. Its market cap has decreased by -10.33% in one year.
Market Cap
133.87B
Enterprise Value
111.02B
Revenue
4.26B
Ranking
n/a
PE Ratio
n/a
Stock Price
9,550.00
Market Cap Chart
Since April 3, 2024, IMB Dx's market cap has decreased from 503.73B to 133.87B, a decrease of -73.42%. That is a compound annual growth rate of -51.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 133.59B | -3.64% |
| Dec 30, 2025 | 138.64B | -7.14% |
| Dec 30, 2024 | 149.29B | -70.36% |
| Apr 3, 2024 | 503.73B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EASY BIO,Inc. | 222.97B |
| Genexine | 221.49B |
| MedPacto | 214.91B |
| Macrogen | 184.74B |
| ENCell | 171.54B |
| GeneOne Life Science | 157.37B |
| Oncocross | 113.85B |
| iNtRON Biotechnology | 106.37B |